News & Insights


Year in Review for Drug and Device Advertising and Promotion – Lessons Learned from 2020 FDA Enforcement Letters and Other Key Developments

Please join our experienced panel for a review of key takeaways from FDA’s 2020 drug and device advertising and promotion enforcement letters and a discussion of related regulatory developments. Learn the issues that were most commonly raised in last year’s letters, as well as other important legal and regulatory developments, and what these could mean for your business, including:

  • 2020 drug and device advertising and promotion enforcement overview
  • 2020 advertising and promotion guidance documents
  • Recent OPDP research initiatives
  • Predictions for what to expect in 2021

If you have questions concerning this roundtable webinar, email Chayako Williams at


King & Spalding is an accredited provider of CLE credit in California, Georgia, Illinois, New York and Texas. We can issue reciprocal credit for attorneys licensed in Connecticut, Florida, and New Jersey. We will apply for credit in Colorado, North Carolina and Virginia (subject to MCLE Board approval). For jurisdictions not listed, attendees are provided with a Universal Certificate of Attendance. New York licensed attorneys: Transitional/Appropriate for newly-admitted and experienced attorneys. Financial aid is available for qualifying lawyers. For CLE-related questions, please contact Gisel Arias, King & Spalding, 1180 Peachtree Street NE, Atlanta, GA 30309. CA Provider #10947.

Event Details

Date: January 27, 2021

Time: 12:00 pm (ET)

Attend This Webinar

Please register soon. You do not have to be a client to attend, and there is no charge.